NPI: 1467476556 · MADILL, OK 73446 · Critical Access Hospital · NPI assigned 07/26/2006
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL) |
| NPI Enumeration Date | 07/26/2006 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,234 | $256K |
| 2019 | 2,796 | $253K |
| 2020 | 2,142 | $183K |
| 2021 | 5,378 | $413K |
| 2022 | 10,199 | $698K |
| 2023 | 11,339 | $746K |
| 2024 | 6,725 | $428K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 10,047 | 9,861 | $1.65M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 2,453 | 2,423 | $600K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3,845 | 3,769 | $147K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,039 | 1,993 | $122K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 6,516 | 3,997 | $113K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 526 | 517 | $73K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 152 | 149 | $53K |
| 80053 | Comprehensive metabolic panel | 2,831 | 2,788 | $44K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,472 | 2,444 | $35K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 407 | 401 | $21K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2,407 | 2,346 | $16K |
| 96361 | Intravenous infusion, hydration; each additional hour | 310 | 306 | $15K |
| 87070 | 1,728 | 1,711 | $13K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 217 | 211 | $10K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 83 | 83 | $9K |
| 71045 | Radiologic examination, chest; single view | 436 | 429 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | 468 | 467 | $8K |
| 80305 | 479 | 475 | $5K | |
| 80061 | Lipid panel | 363 | 362 | $4K |
| 80306 | 245 | 241 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 110 | 110 | $3K |
| 87420 | 183 | 178 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 103 | 99 | $2K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 78 | 73 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | 237 | 232 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | 206 | 205 | $2K |
| 81001 | 470 | 462 | $1K | |
| 85027 | 313 | 312 | $1K | |
| 36415 | Collection of venous blood by venipuncture | 510 | 492 | $1K |
| 70450 | Computed tomography, head or brain; without contrast material | 12 | 12 | $1K |
| 81003 | 382 | 380 | $1K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 56 | 56 | $911.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 331 | 324 | $593.31 |
| 84439 | 92 | 92 | $490.23 | |
| J2060 | Injection, lorazepam, 2 mg | 30 | 29 | $410.96 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 25 | 24 | $325.26 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 16 | 16 | $241.58 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 553 | 549 | $182.43 |
| 83605 | 19 | 16 | $170.10 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 12 | 12 | $112.68 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 12 | 12 | $98.58 |
| 81025 | 14 | 13 | $83.83 | |
| 86308 | 12 | 12 | $54.20 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 13 | 13 | $0.00 |